These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


227 related items for PubMed ID: 37752609

  • 1. Stachydrine ameliorates hypoxia reoxygenation injury of cardiomyocyte via enhancing SIRT1-Nrf2 pathway.
    Zhu X, Wu Y, Zhang X, Gu W, Ning Z.
    J Cardiothorac Surg; 2023 Sep 26; 18(1):265. PubMed ID: 37752609
    [Abstract] [Full Text] [Related]

  • 2. Isorhamnetin protects against hypoxia/reoxygenation-induced injure by attenuating apoptosis and oxidative stress in H9c2 cardiomyocytes.
    Zhao TT, Yang TL, Gong L, Wu P.
    Gene; 2018 Aug 05; 666():92-99. PubMed ID: 29730426
    [Abstract] [Full Text] [Related]

  • 3. Rutin alleviates hypoxia/reoxygenation-induced injury in myocardial cells by up-regulating SIRT1 expression.
    Yang H, Wang C, Zhang L, Lv J, Ni H.
    Chem Biol Interact; 2019 Jan 05; 297():44-49. PubMed ID: 30365940
    [Abstract] [Full Text] [Related]

  • 4. Ginsenoside Rg1 Protects Cardiomyocytes Against Hypoxia/Reoxygenation Injury via Activation of Nrf2/HO-1 Signaling and Inhibition of JNK.
    Li Q, Xiang Y, Chen Y, Tang Y, Zhang Y.
    Cell Physiol Biochem; 2017 Jan 05; 44(1):21-37. PubMed ID: 29130959
    [Abstract] [Full Text] [Related]

  • 5. [Ginsenoside Re regulates mitochondrial biogenesis through Nrf2/HO-1/PGC-1α pathway to reduce hypoxia/reoxygenation injury in H9c2 cells].
    Xin GJ, Chen YY, Liu ZX, Xu SJ, Zhang HY, Guo F, Peng H, Li L, Han X, Liu JX, Fu JH.
    Zhongguo Zhong Yao Za Zhi; 2024 Feb 05; 49(4):1064-1072. PubMed ID: 38621913
    [Abstract] [Full Text] [Related]

  • 6. Dexmedetomidine reversed hypoxia/reoxygenation injury-induced oxidative stress and endoplasmic reticulum stress-dependent apoptosis of cardiomyocytes via SIRT1/CHOP signaling pathway.
    Zhang Y, Zhao Q, Li X, Ji F.
    Mol Cell Biochem; 2021 Jul 05; 476(7):2803-2812. PubMed ID: 33725228
    [Abstract] [Full Text] [Related]

  • 7. Neferine protected cardiomyocytes against hypoxia/oxygenation injury through SIRT1/Nrf2/HO-1 signaling.
    Lu C, Jiang B, Xu J, Zhang X, Jiang N.
    J Biochem Mol Toxicol; 2023 Aug 05; 37(8):e23398. PubMed ID: 37421224
    [Abstract] [Full Text] [Related]

  • 8. Plantamajoside protects H9c2 cells against hypoxia/reoxygenation-induced injury through regulating the akt/Nrf2/HO-1 and NF-κB signaling pathways.
    Zeng G, An H, Fang D, Wang W, Han Y, Lian C.
    J Recept Signal Transduct Res; 2022 Apr 05; 42(2):125-132. PubMed ID: 33349091
    [Abstract] [Full Text] [Related]

  • 9. [Hesperetin Alleviates Doxorubicin-Induced Cytotoxicity in H9c2 Cells by Activating SIRT1/NRF2 Signaling].
    Li X, Yan A, Chang J, Li F, Zhu J.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Sep 05; 54(5):947-953. PubMed ID: 37866951
    [Abstract] [Full Text] [Related]

  • 10. Glaucocalyxin A Protects H9c2 Cells Against Hypoxia/Reoxygenation-Induced Injury Through the Activation of Akt/Nrf2/HO-1 Pathway.
    Peng Z, Zhang R, Pan L, Pei H, Niu Z, Wang H, Lv J, Dang X.
    Cell Transplant; 2020 Sep 05; 29():963689720967672. PubMed ID: 33172292
    [Abstract] [Full Text] [Related]

  • 11. L-Carnitine Reduces Myocardial Oxidative Stress and Alleviates Myocardial Ischemia-Reperfusion Injury by Activating Nuclear Transcription-Related Factor 2 (Nrf2)/Heme Oxygenase-1 (HO-1) Signaling Pathway.
    Zhao T, Chen S, Wang B, Cai D.
    Med Sci Monit; 2020 May 26; 26():e923251. PubMed ID: 32452468
    [Abstract] [Full Text] [Related]

  • 12. Lycium barbarum polysaccharide protects rats and cardiomyocytes against ischemia/reperfusion injury via Nrf2 activation through autophagy inhibition.
    Pan H, Niu L, Wu Y, Chen L, Zhou X, Zhao Y.
    Mol Med Rep; 2021 Nov 26; 24(5):. PubMed ID: 34498711
    [Abstract] [Full Text] [Related]

  • 13. ADAM10 Alleviates Hypoxia/Reoxygenation-Induced Cardiomyocyte Injury by Activating the Notch Signaling Pathway.
    Xu T, Jiang S, Liu T, Han S, Wang Y.
    Cell Biochem Biophys; 2024 Sep 26; 82(3):2523-2532. PubMed ID: 38913282
    [Abstract] [Full Text] [Related]

  • 14. Platycodin D inhibits oxidative stress and apoptosis in H9c2 cardiomyocytes following hypoxia/reoxygenation injury.
    Wang Y, Che J, Zhao H, Tang J, Shi G.
    Biochem Biophys Res Commun; 2018 Sep 18; 503(4):3219-3224. PubMed ID: 30146261
    [Abstract] [Full Text] [Related]

  • 15. Icariin inhibits hypoxia/reoxygenation-induced ferroptosis of cardiomyocytes via regulation of the Nrf2/HO-1 signaling pathway.
    Liu XJ, Lv YF, Cui WZ, Li Y, Liu Y, Xue YT, Dong F.
    FEBS Open Bio; 2021 Nov 18; 11(11):2966-2976. PubMed ID: 34407320
    [Abstract] [Full Text] [Related]

  • 16. Rhodiola wallichiana var.cholaensis protects against myocardial ischemia-reperfusion injury by attenuating oxidative stress-mediated apoptosis via enhancing Nrf2 signaling.
    Yan T, Li X, Wang X, Zhang Y, He B, Jia Y, Xiao W.
    Int J Cardiol; 2023 Aug 01; 384():62-73. PubMed ID: 37178804
    [Abstract] [Full Text] [Related]

  • 17. CTRP13 Protects H9c2 Cells Against Hypoxia/Reoxygenation (H/R)-Induced Injury Via Regulating the AMPK/Nrf2/ARE Signaling Pathway.
    Jiang W, Song J, Zhang S, Ye Y, Wang J, Zhang Y.
    Cell Transplant; 2021 Aug 01; 30():9636897211033275. PubMed ID: 34338573
    [Abstract] [Full Text] [Related]

  • 18. Betulinic acid alleviates myocardial hypoxia/reoxygenation injury via inducing Nrf2/HO-1 and inhibiting p38 and JNK pathways.
    Wang D, Chen T, Liu F.
    Eur J Pharmacol; 2018 Nov 05; 838():53-59. PubMed ID: 30125567
    [Abstract] [Full Text] [Related]

  • 19. [Astragaloside Ⅳ regulates Nrf2/Bach1/HO-1 signaling pathway and inhibits H9c2 cardiomyocyte injury induced by hypoxia-reoxygenation].
    Yang P, Zhou YP, Chang XC, Wang F, Li GW.
    Zhongguo Zhong Yao Za Zhi; 2019 Jun 05; 44(11):2331-2337. PubMed ID: 31359660
    [Abstract] [Full Text] [Related]

  • 20. Astragaloside IV Regulates the PI3K/Akt/HO-1 Signaling Pathway and Inhibits H9c2 Cardiomyocyte Injury Induced by Hypoxia-Reoxygenation.
    Yang P, Zhou Y, Xia Q, Yao L, Chang X.
    Biol Pharm Bull; 2019 May 01; 42(5):721-727. PubMed ID: 30867343
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.